107 related articles for article (PubMed ID: 21470667)
1. Urokinase plasminogen activator receptor levels in Behcet's disease.
Birengel S; Yalçındağ FN; Yalçındağ A; Sahli E; Batıoğlu F
Thromb Res; 2011 Sep; 128(3):274-6. PubMed ID: 21470667
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters.
Najim RA; Sharquie KE; Abu-Raghif AR
J Dermatol; 2007 May; 34(5):308-14. PubMed ID: 17408439
[TBL] [Abstract][Full Text] [Related]
4. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.
Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y
Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand factor antigen levels in Behçet disease.
Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
[TBL] [Abstract][Full Text] [Related]
6. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement.
Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550
[TBL] [Abstract][Full Text] [Related]
7. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
8. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
[TBL] [Abstract][Full Text] [Related]
9. Coagulation and fibrinolytic activity in Behçet's disease.
Hampton KK; Chamberlain MA; Menon DK; Davies JA
Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
Probst K; Fijnheer R; Rothova A
Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
[TBL] [Abstract][Full Text] [Related]
13. Behçet's disease and hearing loss.
AK E; Harputluoglu U; Oghan F; Baykal B
Auris Nasus Larynx; 2004 Mar; 31(1):29-33. PubMed ID: 15041051
[TBL] [Abstract][Full Text] [Related]
14. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
[TBL] [Abstract][Full Text] [Related]
16. Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
Casella R; Shariat SF; Monoski MA; Lerner SP
Cancer; 2002 Dec; 95(12):2494-9. PubMed ID: 12467062
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of liberated domain I of the urokinase plasminogen activator receptor in squamous cell lung cancer tissue.
Almasi CE; Høyer-Hansen G; Christensen IJ; Danø K; Pappot H
Lung Cancer; 2005 Jun; 48(3):349-55. PubMed ID: 15893003
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
19. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
Zhou Q; Liang LJ; Peng BG; Zhen YY
Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
